1: In Vivo. 2005 Jan-Feb;19(1):201-4. 

Possible adjuvant cancer therapy by two prebiotics--inulin or oligofructose.

Taper HS, Roberfroid MB.

Unite de Pharmacocinetique, Metabolisme, Nutrition et Toxicologie, Universite
Catholique de Louvain, 1200 Bruxelles, Belgium. Patricia.Debluts@pmnt.ucl.ac.be

Dietary treatment with inulin or oligofructose incorporated in the basal diet
for experimental animals: (I) reduced the incidence of mammary tumors induced in
Sprague-Dawley rats by methylnitrosourea; (II) inhibited the growth of
transplantable malignant tumors in mice; (III) decreased the incidence of lung
metastases of a malignant tumor implanted intramuscularily in mice. (IV)
Moroever, besides such cancer risk reduction effects, dietary treatment with
inulin or oligofructose significantly potentiated the effects of subtherapeutic
doses of six cytotoxic drugs commonly utilized in human cancer treatment. (V)
The same prebiotics potentiated the effects of radiotherapy on solid form of TLT
tumors to a statistically very high level. Such dietary treatment, with the
inulin or oligofructose potentiating the effects of cancer therapy, might be
introduced into classic protocols of human cancer treatment as a new, non-toxic
and easily applicable adjuvant cancer therapy without any additional risk to
patients.

PMID: 15796175 [PubMed - indexed for MEDLINE]